Regeneron Pharmaceuticals (REGN) Times Interest Earned (2009 - 2026)

Regeneron Pharmaceuticals' Times Interest Earned history runs 17 years deep, the most recent figure standing at $49.84 for Q1 2026.

• In Q1 2026, Times Interest Earned fell 26.72% year-over-year to $49.84; the TTM figure through Mar 2026 stood at $75.61 (down 5.66% YoY), while the FY2025 annual figure was $81.69, up 12.99% from the prior year.
• Times Interest Earned was $49.84 for Q1 2026 at Regeneron Pharmaceuticals, down from $72.12 in the prior quarter.
• In the past five years, Times Interest Earned ranged from a high of $299.86 in Q2 2025 to a low of $46.67 in Q1 2024.
• Historically, Times Interest Earned has averaged $81.58 across 5 years, with a median of $68.01 in 2025.
• The sharpest annual moves came in 2022 and 2025: Times Interest Earned tumbled 64.8% in 2022, then jumped 314.92% in 2025.
• A 5-year view of Times Interest Earned shows it stood at $65.91 in 2022, then slipped by 19.34% to $53.16 in 2023, then surged by 77.38% to $94.3 in 2024, then fell by 23.52% to $72.12 in 2025, then sank by 30.9% to $49.84 in 2026.
• The last three Times Interest Earned figures came in at $49.84 (Q1 2026), $72.12 (Q4 2025), and $53.2 (Q3 2025), per Business Quant data.